Lecanemab
Health
FDA Approves the Leqembi Drug that Slows Alzheimer’s Progress
The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen and Eisai Alzheimer’s treatment Leqembi.
Leqembi, also known as lecanemab, is the first drug shown to slow the progress of the disease, rather than just treating...
Health
New Alzheimer’s Drug Slows the Disease by a Third
A new Alzheimer's drug called Donanemab has shown promising results in slowing down the disease's progression, which is caused by a sticky substance called beta-amyloid that builds up in the brain. Donanemab works similarly to another drug called Lecanemab,...
Health
New Alzheimer’s Drug Designed to Slow Disease Approved by FDA
The FDA has approved a new drug shown to slow down the early stages of Alzheimer’s despite controversy surrounding some of its more serious side effects.
Lecanemab, the first drug to actively decelerate the progress of the disease, seems to...
Europe
First Drug Slows Brain Destruction in Alzheimer’s Patients
Researchers have announced the very first drug that slows brain destruction in Alzheimer's patients, thought it is still in the early stages of development.
The drug known as lecanemab is part of a new era of drugs for treating Alzheimer's,...